Cargando…
MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2
Drug resistance occurs commonly in cancers, especially in hepatocellular carcinoma (HCC). Accumulating evidence has demonstrated that microRNAs (miRNAs) play a vital role in tumour chemoresistance. However, little is known about the role of miR‐383 in HCC chemoresistance. In the present study, RT‐PC...
Autores principales: | Tu, Chaoyong, Chen, Wei, Wang, Shuqian, Tan, Wei, Guo, Jingqiang, Shao, Chuxiao, Wang, Weilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815770/ https://www.ncbi.nlm.nih.gov/pubmed/30801960 http://dx.doi.org/10.1111/jcmm.14197 |
Ejemplares similares
-
A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis
por: Yi, Qian, et al.
Publicado: (2022) -
MicroRNA-875-5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a
por: Chen, Tianxiang, et al.
Publicado: (2020) -
MicroRNA‐383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8
por: Cheng, Yan, et al.
Publicado: (2020) -
Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy
por: Wu, YiFeng, et al.
Publicado: (2021) -
The value of preoperative systemic immune-inflammation index in predicting vascular invasion of hepatocellular carcinoma: a meta-analysis
por: Wu, YiFeng, et al.
Publicado: (2021)